Search Results
Richard Maziarz, MD: Tisagenlecleucel induces durable response among adults with pretreated DLBCL
Dr. Maziarz on Sustained Responses With Tisagenlecleucel in DLBCL
Dr. Maziarz Discusses Promise of Tisagenlecleucel in DLBCL
Latest results from JULIET: Tisagenlecleucel in adults with DLBCL
Dr. Maziarz on Unanswered Questions With CAR T-Cell Therapy in DLBCL
CAR-T gives sustained disease control in R/R adult DLBCL: updated JULIET analysis
Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment...
Richard Maziarz: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleuc...
Richard Maziarz | EBMT 2019 | Grading cytokine release syndrome and neurotoxicity in CAR T trials
Livestream von oncoletter
Wise words from Gen (R) Richard A. Cody #military #army
UofL Dept. of Medicine Grand Rounds: Dr. Mohamed Kharfan-Dabaja (2023 Lung T. Yan, M.D. Lecture)
